XML 20 R28.htm IDEA: XBRL DOCUMENT v3.20.1
INCOME TAXES (Tables)
12 Months Ended
Dec. 31, 2019
Income Tax Disclosure [Abstract]  
Schedule of Deferred Tax Assets and Liabilities
   Years Ended December 31, 
   2019   2018 
Deferred Tax Assets:        
Tax benefit of net operating loss carry-forward  $11,828,268   $6,465,826 
Depreciation and amortization   27,949    (5,102)
Accrued liabilities   360,204    261,876 
Stock based compensation   34,493    - 
Interest Expense   -    740,285 
R&D Credit   851,413    393,165 
Total deferred tax assets   13,102,327    7,856,050 
Valuation allowance for deferred tax assets   (13,102,327)   (7,856,050)
Deferred tax assets, net of valuation allowance  $-   $- 
Summary of Valuation Allowance
   Years Ended December 31, 
   2019   2018 
Beginning of the year  $7,856,050   $4,726,411 
Change in valuation account   5,246,277    3,129,639 
End of the year  $13,102,327   $7,856,050 
Schedule of Effective Income Tax Rate Reconciliation
   Years Ended December 31, 
   2018   2018 
U.S. federal statutory rate   (21.0)%   (21.0)%
Federal true ups   0.8%     
State taxes, net of federal benefit   (6.2)%   (6.9)%
Share-based compensation   -%   -%
Effect of U.S. tax law change   -%   -%
Change in valuation allowance   27.1%   25.8%
           
Nondeductible expenses   0.5%   2.0%
R&D credit   (2.4)%   (3.2)%
Stock Options   -%   3.3%
Foreign rate differential   (0.2)%     
China liquidation   1.4%     
Effective income tax rate   -%   -%